Calls for papers
-
The FDA has approved AstraZeneca’s Bevespi Aerosphere glycopyrrolate/formoterol fumarate MDI (formerly PT003) for the treatment of COPD, the company has announced. The product is AstraZeneca’s first to use the Co-Suspension technology patented by Pearl Therapeutics… Read more . . .
-
The US FDA has issued four new product-specific draft guidances in April 2016 for inhalation products, including three dry powder products and one MDI. The documents include recommendations on establishing bioequivalence for generic versions of… Read more . . .
-
Aytu BioScience has acquired US rights to Natesto testosterone nasal gel from Acerus (formerly Trimel) for $8 million up front, including $2 million on signing and an additional $6 million by the end of FY… Read more . . .
-
3M Drug Delivery Systems has announced the launch of the 3M Intelligent Control Inhaler, a connected, breath-actuated inhaler that provides instructions to the patient via a screen integrated into the device and provides feedback to… Read more . . .
-
The United States Patent and Trademark Office has issued US Patent 9,248,076 B2, titled “Dose Dispensing Containers,” to Mystic Pharmaceuticals, the company has announced. The patent covers nose-to-brain delivery systems for therapies to treat brain… Read more . . .
-
Aptar Pharma has announced the launch of its new eDose counter for MDIs at RDD 2016. According to the company, the eDose counter can be used with any metering valve; the counter’s sensor detects the… Read more . . .
-
GlaxoSmithKline has opened a new £56 million, 4500 m2 manufacturing facility for its Ellipta DPI products. According to GSK, the new facility will create 150 jobs and will double production of Ellipta inhalers at the… Read more . . .
-
Discovery Laboratories, which is developing Aerosurf aerosolized KL4 surfactant for the treatment of respiratory distress syndrome in premature infants, has changed its name to Windtree Therapeutics, the company said. CEO Craig Fraser, who was appointed… Read more . . .
-
Swedish CDMO Recipharm has announced that it will acquire Kemwell’s CDMO business, including North Carolina-based Cirrus Pharmaceuticals. Kemwell acquired Cirrus Pharmaceuticals, which offers OINDP development and manufacturing services, in 2013. In February 2016, Cirrus Pharmaceuticals… Read more . . .
-
The Medicon Valley Inhalation Consortium (MVIC) has announced the appointment of Lars Asking as VP as of May 1, 2016. Asking was most recently Principle Scientist at Novo Nordisk and previously developed inhaled products at… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland